Mariner
ABVX

Mariner’s Abivax ABVX Stock Holding History

Mariner’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Sell
7,855
-3,151
-29% -$357K ﹤0.01% 1920
2026
Q1 		$1.22M Buy
11,006
+2,025
+23% +$240K ﹤0.01% 1831
2025
Q4 		$1.21M Buy
8,981
+1,087
+14% +$119K ﹤0.01% 1815
2025
Q3 		$670K Buy
+7,894
New +$484K ﹤0.01% 2202

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mariner's ABVX Position: Q2 2026 in Review

Mariner reduced its Abivax (ABVX) stake by 29% in Q2 2026, selling an estimated $357K and leaving 7,855 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1920.

Mariner first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.22M in Q1 2026. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Mariner held 7,855 shares of Abivax worth $1.05M as of Q2 2026.
  • Mariner sold 3,151 Abivax shares in Q2 2026, an estimated $357K.
  • Abivax made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #1920 holding.
  • Mariner first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • Mariner's Abivax position peaked at $1.22M in Q1 2026.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.